Phreesia (PHR) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results
Yahoo FinanceNov 1 06:48 ET
Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration
BusinesswireOct 28 06:48 ET
Phreesia, Inc.'s (NYSE:PHR) Price In Tune With Revenues
Simply Wall StOct 23 07:45 ET
Is Phreesia, Inc. (NYSE:PHR) The Top Stock With Improving Technical Ratings According To Piper Sandler?
Yahoo FinanceOct 11 12:14 ET
Down -10.25% in 4 Weeks, Here's Why Phreesia (PHR) Looks Ripe for a Turnaround
Zacks Oct 10 08:50 ET
Phreesia Joins the Network Advertising Initiative as a Member, Demonstrating Ongoing Commitment to Industry-Leading Privacy Practices
BusinesswireOct 8 06:48 ET

Comments

Stock_Drift

Sep 15 13:27

$Phreesia (PHR.US)$

Moomoo AI

Dec 19, 2023 01:57

Investor confidence, reflected in a high P/S ratio and increasing share prices despite fluctuations, suggests anticipated persistent growth in Phreesia. Caution advised over sole reliance on price-to-sales ratios for investment decisions.

Phreesia, Inc.'s (NYSE:PHR) P/S Is Still On The Mark Following 43% Share Price Bounce

Moomoo Breakfast US

Jun 3, 2022 07:29

Columns Today's pre-market stock movers: TSLA, CHGG, OKTA, TPTX and more

Gainers:
• $Okta (OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo (STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics (TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals (AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...

25

2

Analysts Notebook

Apr 14, 2022 06:26

Columns Top upgrades and downgrades on 4/14

Upgrades
• $CDW Corp (CDW.US)$: Stifel Upgrades to Buy from Hold - PT $210 (from $200)
• $Corteva (CTVA.US)$ : Loop Capital Upgrades to Buy from Hold - PT $69
• $CoreCivic, Inc. (CXW.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $17 (from $10.85)
• $Delta Air Lines (DAL.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $60 (from $42)
• $H.B. Fuller (FUL.US)$ : Baird Upgrades to Outperform from Neutral - PT $85
• $Huntington Ingalls Industries (HII.US)$ : Cowen U...

19

Moomoo Breakfast US

Mar 31, 2022 07:53

Columns Today's pre-market stock movers: CLVS, PATH, DARE and more

Gainers:
• $Clovis Oncology (CLVS.US)$ +40.6% (Rubraca significantly improves progression-free survival in first-line maintenance treatment in women with ovarian cancer regardless of their biomarker status in phase 3 athena-mono trial)
• $Dare Bioscience (DARE.US)$ +13.61% (Organon and Dar Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO)
• $KULR Technology (KULR.US)$ +9.5% (secured a battery sa...

14

PHR Phreesia

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target